223 related articles for article (PubMed ID: 27060935)
1. A 6-year treatment experience for pemphigus: retrospective study of 69 Chinese patients.
Bai YX; Zhang LM; Xiao T; Chen HD
Dermatol Ther; 2016; 29(2):84-7. PubMed ID: 27060935
[TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Kim MR; Kim HC; Kim SC
Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
[TBL] [Abstract][Full Text] [Related]
3. Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus.
Cummins DL; Mimouni D; Anhalt GJ; Nousari CH
J Am Acad Dermatol; 2003 Aug; 49(2):276-80. PubMed ID: 12894077
[TBL] [Abstract][Full Text] [Related]
4. Pemphigus vulgaris and pemphigus foliaceus: similar prognosis?
Zaraa I; Mokni M; Hsairi M; Boubaker S; Sellami M; Zitouni M; Makni S; Dhahri AB
Int J Dermatol; 2007 Sep; 46(9):923-6. PubMed ID: 17822493
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs.
Grando SA
Int J Dermatol; 2019 Jan; 58(1):114-125. PubMed ID: 30047585
[TBL] [Abstract][Full Text] [Related]
6. Current biologics in treatment of pemphigus foliaceus: a systematic review.
Carver CA; Kalesinskas M; Ahmed AR
Front Immunol; 2023; 14():1267668. PubMed ID: 37901249
[TBL] [Abstract][Full Text] [Related]
7. Four mild but refractory cases of pemphigus foliaceus successfully treated with intravenous immunoglobulin.
Kawakami T; Koga H; Saruta H; Ueda A; Inoue Y; Soma Y; Ishii N; Hashimoto T
J Dermatol; 2013 Nov; 40(11):869-73. PubMed ID: 24127870
[TBL] [Abstract][Full Text] [Related]
8. Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.
De Simone C; Caldarola G; Perino F; Venier A; Guerriero G
Dermatol Ther; 2012; 25(2):219-22. PubMed ID: 22741942
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
[TBL] [Abstract][Full Text] [Related]
10. Pemphigus in Korea: clinical manifestations and treatment protocol.
Seo PG; Choi WW; Chung JH
J Dermatol; 2003 Nov; 30(11):782-8. PubMed ID: 14684934
[TBL] [Abstract][Full Text] [Related]
11. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
[TBL] [Abstract][Full Text] [Related]
12. Three cases of transition from pemphigus vulgaris to pemphigus foliaceus confirmed by desmoglein ELISA.
Ng PP; Thng ST
Dermatology; 2005; 210(4):319-21. PubMed ID: 15942219
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and clinical characteristics of patients with pemphigus treated in Białystok in 2001-2018.
Serwin AB; Flisiak I
Przegl Epidemiol; 2020; 74(3):457-465. PubMed ID: 33570343
[TBL] [Abstract][Full Text] [Related]
14. Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.
Kridin K; Zelber-Sagi S; Bergman R
Acta Derm Venereol; 2017 Oct; 97(9):1095-1099. PubMed ID: 28536732
[TBL] [Abstract][Full Text] [Related]
15. Pemphigus vulgaris: a clinical study of 44 cases over a 20-year period.
Svecova D
Int J Dermatol; 2015 Oct; 54(10):1138-44. PubMed ID: 26394602
[TBL] [Abstract][Full Text] [Related]
16. Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.
Bongiorno MR; Pistone G; Doukaki S; Aricò M
Int J Dermatol; 2010 Jun; 49(6):693-9. PubMed ID: 20618478
[TBL] [Abstract][Full Text] [Related]
17. [Transition from pemphigus vulgaris to pemphigus foliaceus: a case report].
Lévy-Sitbon C; Reguiaï Z; Durlach A; Goeldel AL; Grange F; Bernard P
Ann Dermatol Venereol; 2013 Dec; 140(12):788-92. PubMed ID: 24315225
[TBL] [Abstract][Full Text] [Related]
18. Is transition between subtypes of pemphigus possible? A series of pemphigus vulgaris patients showing the transition to pemphigus foliaceus.
Kucukoglu R; Atci T; Sun GP
An Bras Dermatol; 2023; 98(6):787-792. PubMed ID: 37357115
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Werth VP
Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
van Beek N; Eming R; Reuss A; Zillikens D; Sárdy M; Günther C; Kiritsi D; Benoit S; Beissert S; Gläser R; Gollnick H; Horváth ON; Pfeiffer C; Röcken M; Schauer F; Schreml S; Steinbrink K; Zink A; Schade-Brittinger C; Hertl M; Schmidt E
Br J Dermatol; 2024 Apr; 190(5):657-667. PubMed ID: 38133541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
